Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases

The discovery of EGFR mutations and EML4-ALK gene rearrangements has radically changed the therapeutic scenario for patients with advanced non-small cell lung cancer. ALK and EGFR tyrosine-kinase inhibitors showed better activity and efficacy than standard chemotherapy in the first and second line t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Russo, Giuseppe, Imbimbo, Martina, Corrao, Giulia, Proto, Claudia, Signorelli, Diego, Vitali, Milena, Ganzinelli, Monica, Botta, Laura, Zilembo, Nicoletta, de Braud, Filippo, Garassino, Marina Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601787/
https://www.ncbi.nlm.nih.gov/pubmed/28938691
http://dx.doi.org/10.18632/oncotarget.17431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601787/
https://www.ncbi.nlm.nih.gov/pubmed/28938691
http://dx.doi.org/10.18632/oncotarget.17431

Ejemplares similares